Knight Therapeutics Inc.

Knight Therapeutics Inc.verified

KHTRF

Price:

$3.8

Market Cap:

$535.51M

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib to treat metastatic cholangiocarcinoma; Trelstar for advanced prostate cancer and for pain associated with endometriosis; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic adenocarcinoma; Halaven for metastatic breast cancer and doft tissue sarcoma; and Lenvima for ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2014-04-03

Stock Exchange

PNK

Ticker

KHTRF

The Dividend Yield as of November 2024 (TTM) for Knight Therapeutics Inc. (KHTRF) is 0%

According to Knight Therapeutics Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Knight Therapeutics Inc. (KHTRF) Historical Dividend Yield (quarterly & annually)

How has KHTRF Dividend Yield performed in the past?

The mean historical Dividend Yield of Knight Therapeutics Inc. over the last ten years is 6.35%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), KHTRF's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

6.35%

Median

0%

Minimum

0%

Maximum

63.48%

Knight Therapeutics Inc. (KHTRF) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Knight Therapeutics Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 63.48%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%-100.00%
201463.48%Infinity%

Knight Therapeutics Inc. (KHTRF) Average Dividend Yield

How has KHTRF Dividend Yield performed in the past?

The current Dividend Yield of Knight Therapeutics Inc. (KHTRF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

6.35%

Knight Therapeutics Inc. (KHTRF) Dividend Yield vs. Peers

How is KHTRF’s Dividend Yield compared to its peers?

Knight Therapeutics Inc.’s Dividend Yield is less than Crescita Therapeutics Inc. (0%), less than Cipher Pharmaceuticals Inc. (0%), less than Cannara Biotech Inc. (0%), less than Lowell Farms Inc. (0%), less than Aion Therapeutic Inc. (0%), less than HLS Therapeutics Inc. (0%), less than Canntab Therapeutics Limited (0%), less than Bionoid Pharma Inc. (0%), less than CENTR Brands Corp. (0%), less than RAMM Pharma Corp. (0%), less than Craftport Cannabis Corp. (0%), less than Speakeasy Cannabis Club Ltd. (0%), less than City View Green Holdings Inc. (0%), less than RavenQuest BioMed Inc. (0%),

Build a custom stock screener for Knight Therapeutics Inc. (KHTRF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Knight Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Knight Therapeutics Inc. (KHTRF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Knight Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Knight Therapeutics Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Knight Therapeutics Inc. (KHTRF)?

What is the highest Dividend Yield for Knight Therapeutics Inc. (KHTRF)?

What is the 3-year average Dividend Yield for Knight Therapeutics Inc. (KHTRF)?

What is the 5-year average Dividend Yield for Knight Therapeutics Inc. (KHTRF)?

How does the current Dividend Yield for Knight Therapeutics Inc. (KHTRF) compare to its historical average?